Collin Rich, Ph.D.

CTO

In addition to co-founding Aquaro Biosystems, Collin’s experience includes launching and managing R&D efforts at five different medical device start-ups over the past 15 years, including as co-founder of Accuri Cytometers, which was ultimately sold to Becton Dickinson. His formal training as an Electrical Engineer is augmented by familiarity with a wide variety of mechanical, fluidic, and other technologies, as well as practical experience managing the fast-paced activity of an aggressive, innovative R&D team. Collin is co-inventor on over 42 U.S. and international patents.